EUVIMED · CrossrefZeitschrift
Evidence-based Oncology
ISSN 1363-4054 · Elsevier BV
Neueste Artikel
Editorial
EDITORIAL
Table A. Levels of evidence and grades of recommendations
Glossary of terms
EDITORIAL
Glossary of terms
Table A. Levels of evidence and grades of recommendations
EDITORIAL
Glossary of terms
Table A. Levels of evidence and grades of recommendations
Glossary of terms
Why evidence-based oncology?
Glossary of terms
Digital rectal examination is of limited value as a screening test for prostate cancer
Tumor thickness predicts a five-year survival equally as well as more complex prognostic model
A prognostic score for advanced Hodgkin's disease
Risk of breast cancer among BRCA2 mutation carriers lower than previously estimated
Irinotecan increased survival in patients with advanced colorectal cancer
Editorial
Thalidomide is active drug against myeloma that failed transplant
Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML
Treatment effectiveness of high-risk neuroblastoma is improved with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13- cis -retinoic acid
TREATMENT/INTERVENTION
Dacarbazine remains the reference standard treatment for metastatic melanoma
Differential time to positivity (DTP) of hub blood vs peripheral blood reliably diagnoses catheter-related infection
EBV type 2 infection or superinfection does not contribute to development of AIDS-related non-Hodgkin's lymphoma
PROGNOSIS
TT virus infection is common in transfusion-dependent patients with β-thalassemia and in healthy blood donors
Transfusion-transmitted virus may play a limited role in hepatitis following bone marrow transplantation
ETIOLOGY
EUVIMED